# Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus

> **NCT01129778** · NA · TERMINATED · sponsor: **Stanford University** · enrollment: 27 (actual)

## Conditions studied

- Barrett Esophagus
- Gastroesophageal Reflux

## Interventions

- **DRUG:** Zegerid (proton pump inhibitor)
- **PROCEDURE:** Bravo pH monitoring

## Key facts

- **NCT ID:** NCT01129778
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2010-07
- **Final completion:** 2010-12
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** change in the business strategy of the sponsor
- **Last updated:** 2017-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129778, "Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01129778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*